http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1314405-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9316ec7697910c934dd14c9dc70ca5f6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
filingDate 2002-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53acd8611b8ea8b961d383b740dafcb2
publicationDate 2007-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1314405-B1
titleOfInvention Graft with proliferation-inhibiting substance
abstract An implant (1), with main structure (2) comprises a first substance (4) inhibiting cell proliferation and a second decomposable substance (5) which initially prevents contact between the first substance and the surroundings of the main structure. The second substance is constituted such that contact takes place only after a body tissue covering at least a section of the main structure has formed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7938855-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8900292-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8216632-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8002823-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8771343-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8071156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8431149-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8231980-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8221822-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9284409-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8287937-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8187620-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8449603-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8066763-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8920491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7931683-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8353949-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8029554-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7976915-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7981150-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8932346-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815273-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8070797-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8574615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8067054-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815275-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7942926-B2
priorityDate 2001-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122

Total number of triples: 48.